What Is TMO Fair Value?
Thermo Fisher Scientific Inc. (TMO) fair value estimate using multiple valuation models, updated daily.
As of October 31, 2026, Thermo Fisher Scientific Inc. (TMO) has a composite fair value estimate of $295.27 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $697.00, suggesting the stock is overvalued by 57.6%.
Data as of October 31, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$295.27
vs. current price of $697.00(-57.6%)
How Is TMO Fair Value Calculated?
Four independent models estimate what TMO is worth. Each uses different inputs and assumptions. The composite blends them by weight.
TMO Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$368.10
-47.2%Overvalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$46.55
-93.3%Overvalued
Inputs used
TMO Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$290.11
-58.4%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$256.75
-63.2%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $697.00 is 47.2% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $7.10B | $6.54B |
| Year 2 | $7.82B | $6.64B |
| Year 3 | $8.62B | $6.73B |
| Year 4 | $9.49B | $6.83B |
| Year 5 | $10.46B | $6.93B |
| Year 6 | $11.52B | $7.03B |
| Year 7 | $12.69B | $7.13B |
| Year 8 | $13.98B | $7.24B |
| Year 9 | $15.40B | $7.34B |
| Year 10 | $16.97B | $7.45B |
| Terminal Value | $286.02B | $125.57B |
What Are TMO's Key Financial Metrics?
Earnings & Growth
Current Price
$697.00
EPS (TTM)
$18.96
Forward P/E
25.1
Profit Margin
14.9%
Cash & Balance Sheet
Free Cash Flow
6.4B
EBITDA
12.2B
Book Value
$148.02
Total Debt
41.4B
What Do Analysts Say About TMO?
Low
$590.00
Average
$752.12
High
$830.00
Upside
+7.9%
TMO Fair Value FAQ
What is the fair value of TMO?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), TMO's estimated fair value is $295.27. The stock is currently trading at $697.00, which makes it overvalued by our analysis.
How is TMO's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is TMO overvalued or undervalued?
Based on our analysis, TMO is overvalued. The current price of $697.00 is 57.6% above our estimated fair value of $295.27.
What do Wall Street analysts say about TMO?
25 analysts cover Thermo Fisher Scientific Inc. with a consensus rating of "Strong Buy." The average price target is $752.12, ranging from $590.00 to $830.00. This implies 7.9% upside from the current price.